Guangzhou Baiyunshan Pharmaceutical Holdings
600332.SS
#2705
Rank
NZ$10.16 B
Marketcap
NZ$6.25
Share price
-0.40%
Change (1 day)
0.58%
Change (1 year)

Earnings for Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SS)

Earnings in 2025 (TTM): NZ$0.81 Billion

According to Guangzhou Baiyunshan Pharmaceutical Holdings's latest financial reports the company's current earnings are NZ$10.55 Billion. In 2024 the company made an earning of NZ$0.86 Billion a decrease over its 2023 earnings that were of NZ$1.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guangzhou Baiyunshan Pharmaceutical Holdings from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.81 B-5.15%
2024 NZ$0.86 B-30.8%
2023 NZ$1.24 B-4.38%
2022 NZ$1.30 B4.32%
2021 NZ$1.24 B35.17%
2020 NZ$0.92 B-10.54%
2019 NZ$1.03 B-1.38%
2018 NZ$1.04 B64.22%
2017 NZ$0.63 B27.61%
2016 NZ$0.49 B12.59%
2015 NZ$0.44 B9.34%
2014 NZ$0.40 B6.26%
2013 NZ$0.38 B162.26%
2012 NZ$0.14 B63.15%
2011 NZ$89.17 M9.1%
2010 NZ$81.73 M40.76%
2009 NZ$58.06 M9.3%
2008 NZ$53.12 M-50.94%
2007 NZ$0.10 B32.74%
2006 NZ$81.57 M26.99%
2005 NZ$64.23 M84.93%
2004 NZ$34.73 M-41.1%
2003 NZ$58.97 M-0.86%
2002 NZ$59.49 M